Clinical Trials Directory

Trials / Completed

CompletedNCT03285074

The Impact of Misclassification of Obesity by Body Mass Index on Mortality in Patients With Chronic Kidney Disease

Status
Completed
Phase
Study type
Observational
Enrollment
326 (actual)
Sponsor
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation · Academic / Other
Sex
All
Age
18 Years – 90 Years
Healthy volunteers
Not accepted

Summary

Unlike the general population, a higher body mass index (BMI) is associated with greater survival among patients with chronic kidney disease (CKD). However, obesity is defined as excess body fat that associated with clearly elevated health risks according to the World Health Organization. In addition, muscle wasting is prevalent among CKD subjects. Thus, we hypothesized that different definition of obesity, based on BMI or body fat percentage, might have different impact on clinical outcomes among CKD population.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionNo intervention

Timeline

Start date
2011-11-01
Primary completion
2012-12-01
Completion
2017-03-31
First posted
2017-09-15
Last updated
2017-09-15

Source: ClinicalTrials.gov record NCT03285074. Inclusion in this directory is not an endorsement.

The Impact of Misclassification of Obesity by Body Mass Index on Mortality in Patients With Chronic Kidney Disease (NCT03285074) · Clinical Trials Directory